Illumina asks court to halt BGI’s sequencer distribution

Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Illumina secures injunction against BGI

18 June 2020 Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.

Big Pharma

BGI counter sues Illumina for patent infringement

4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.

Americas

Illumina accuses BGI of patent infringement, again

2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.

More features

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation: Follow the money (Part I)

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

GSK escalates mRNA COVID-19 vaccine dispute

Illumina asks court to halt BGI’s sequencer distribution

More on this story

Editor's picks

Editor's picks

More features